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Abstract
Colon tumors grow in an adipose tissue-enriched microenvironment. Locally advanced colon cancers often invade
into surrounding adipose tissue with a direct contact with adipocytes. We have previously shown that adipocytes
promote tumor growth by modulating cellular metabolism. Here we demonstrate that carnitine palmitoyltransferase I
(CPT1A), a key enzyme controlling fatty acid oxidation (FAO), was upregulated in colon cancer cells upon exposure to
adipocytes or fatty acids. In addition, CPT1A expression was increased in invasive tumor cells within the adipose tissue
compared to tumors without direct contact with adipocytes. Silencing CPT1A abolished the protective effect provided
by fatty acids against nutrient deprivation and reduced tumor organoid formation in 3D culture and the expression of
genes associated with cancer stem cells downstream of Wnt/β-catenin. Mechanistically, CPT1A-dependent FAO
promoted the acetylation and nuclear translocation of β-catenin. Furthermore, knockdown of CPT1A blocked the
tumor-promoting effect of adipocytes in vivo and inhibited xenograft tumor initiation. Taken together, our ﬁndings
identify CPT1A-depedent FAO as an essential metabolic pathway that enables the interaction between adipocytes and
colon cancer cells.

Introduction
Altered metabolism has been recognized as a common
hallmark of cancer1,2. Emerging evidence indicates that
the tumor microenvironment (TME) is essential in
shaping the landscape of cancer metabolism3. A proﬁle of
the components in the TME revealed that adipocytes
constitute a major cell type that is abundantly associated
with tumor cells4. Metastatic colon cancer cells often
encounter adipocytes as they ﬁrst disseminate from their
primary tumor site. Previous studies indicated that
cancer-associated adipocytes promote tumor growth and
progression by secreting growth factors and proinﬂammatory cytokines into the TME5,6. However, it is less
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understood how the direct interaction with adipocytes
alters tumorigenic properties of cancer cells.
Recently, it has been shown that lipids produced in
adipocytes can be transferred to cancer cells to promote
tumor growth in ovarian cancer models, suggesting that
local adipose tissues may have a direct role in supporting
cancer cells7. Additionally, we reported that the uptake of
fatty acids from adipocytes allows colon cancer cells to
survive nutrient deprivation conditions by upregulating
mitochondrial fatty acid oxidation (FAO)8. This transfer
of fatty acids from adipocytes to cancer cells has been
demonstrated in breast and melanoma cancer models as
well9,10. Interestingly, the presence of cancer cells stimulates the release of fatty acids by promoting lipolysis in
adipocytes, thus indicating a two-way communication
between cancer cells and adipocytes in the TME7,8. Furthermore, treatment with fatty acids enhances the
expression of genes associated with colon cancer stem
cells (CSCs) and suppresses genes associated with
intestinal epithelial cell differentiation8. This ﬁnding is
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consistent with the notion of CSC plasticity in that nonCSCs are capable of converting to CSCs given the right
cue presented by the TME11–13. Taken together, these
studies suggest that the close interaction between adipocytes and cancer cells plays an important role in regulating cancer metabolism.
Although the transfer of fatty acids from adipocytes to
cancer cells has been conﬁrmed in several studies7–10,
the molecular mechanism underlying fatty acidsdependent metabolic regulation in cancer cells remains
elusive. Here we further determined the role of CPT1A, a
rate-limiting enzyme required for mitochondrial FAO, in
mediating the tumor-promoting effect of adipocytes in
colon cancer. Using primary colon cancer cells, 3D
tumor organoids and in vivo xenograft models, we
showed that uptake of fatty acids promotes the expression of CPT1A through the activation of PPARδ. Consequently, knockdown of CPT1A attenuated fatty acid
utilization and eliminated the pro-survival advantage
provided by adipocytes. In addition, we identiﬁed
β-catenin acetylation as a novel mechanism connecting
upregulation of FAO with increased Wnt/β-catenin signaling. Together, results from our study provided new
mechanistic insights into the tumor-promoting effect of
adipocytes in colon cancer.

Materials and methods
Cells and reagents

Patient-derived colon cancer PT130 cells were established as described previously8,14. Human colon cancer
SW480 cells were purchased from ATCC. Both cell
lines were maintained in DMEM supplemented with 10%
fetal bovine serum (FBS, Sigma-Aldrich) and 1%
penicillin–streptomycin. The cell lines were authenticated
using short tandem repeat (STR) DNA proﬁling and tested
negative for mycoplasma contamination (Genetica). The
shRNA-targeting sequences for human CPT1A are as the
following: 5′- GCCATGAAGCTCTTAGACAAA-3′ (C6),
and 5′-CGATGTTACGACAGGTGGTTT-3′ (C7); and for
mouse Cpt1a is: 5′-GCTATGGTGTTTCCTACATTA-3′.
The following reagents were obtained from commercial
sources as speciﬁed below: Acetyl-Coenzyme A Assay Kit,
oleic acid (OA) (albumin complex), palmitic acid (PA),
linoleic acid (LA) (albumin complex), octanoate,
GW501516, GSK3787, and etomoxir (ETO) were from
Sigma-Aldrich; BIODPY 493/503, N-2, and B-27 supplement were from Thermo Fisher Scientiﬁc. Bovine serum
albumin (BSA)-conjugated palmitate was prepared
according to the Seahorse protocol (Seahorse Bioscience).
The concentrations of long chain fatty acids used in the
cell treatment experiments (100–200 μM) are below the
average plasma fatty acid concentrations found in healthy
people15. For fatty acid treatment experiments, cells were
cultured in low glucose media (5 mM, which is close
Ofﬁcial journal of the Cell Death Differentiation Association
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to the normal blood glucose level) supplemented with
10% lipoprotein-deﬁcient bovine serum (Alfa Aesar,
J65182AMG). The octanoate concentration (3 mM) used
for treating cells was based on the amount of octanoate
needed to induce the expression genes related to “fatty
acid metabolic process” as described previously16.
Isolation of human mature adipocytes

Human omental or mesenteric fat tissues were collected
from colon cancer patients undergoing surgery at the
University of Kentucky Markey Cancer Center. The process for patients’ material collection was approved by the
University of Kentucky’s Ofﬁce for the Protection of
Human Subjects. The isolation of adipocytes was carried
out as described previously8. Equal amount of adipocytes
were used as determined by the packed cell volume in all
experiments (the density of puriﬁed adipocytes used is
~1–2 × 106 cells/ml).
Immunohistochemical (IHC) staining

Parafﬁn-embedded colon cancer patient specimens
were obtained from the Biospecimen Procurement and
Translational Pathology Shared Resource Facility of the
Markey Cancer Center. The diagnosis and staging of each
cancer case were conﬁrmed by pathologist. IHC staining
of parafﬁn-embedded tissue sections was performed as
previously described8,17. The CPT1A antibody (#12252)
was obtained from Cell Signaling. The stained sections
were visualized using a Nikon Eclipse 80i upright microscope. To quantify the relative CPT1A expression levels,
pixel intensity values were used to deﬁne the percentage
of tumor cells with positive staining using the HALO
image analysis platform (Indica Labs).
Measurements of cellular acetyl-CoA (Ac-CoA) levels

The cellular levels of Ac-CoA were determined using
the Acetyl-Coenzyme A Assay Kit (Sigma-Aldrich).
Brieﬂy, cells were cultured in low glucose media supplemented with 10% FBS. Total of 106 cells were trypsinized,
lysed in perchloric acid and neutralized using KHCO3.
After centrifuging at 13,000 × g for 10 min, supernatants
were collected and used for Ac-CoA measurements. The
protein contents in the pellets were determined using the
BCA Protein Assay Kit. The levels of Ac-CoA were presented as pmol/mg of protein.
Seahorse extracellular ﬂux analysis

The Seahorse XF96 Extracellular Flux Analyzer (Agilent) was used to measure the respiration activity of colon
cancer cells as described previously8,14,18. The mitochondrial stress tests were performed according to manufacturer’s protocol. The relative levels of basal and
maximal respiration were calculated based on OCR data
obtained in the Mito stress tests. The FAO assays were
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performed as previously described with the following
modiﬁcations8. Brieﬂy, cells were seeded at the density of
3 × 104 cells per well in a XF96 plate and subsequently
incubated in substrate-limited medium (DMEM with
0.5 mM glucose, 1.0 mM glutamine, 0.5 mM carnitine,
and 1% FBS) for ~16 h. Prior to the beginning of FAO
measurements, the medium was switched into FAO assay
medium (200 μM palmitate–BSA, 111 mM NaCl, 4.7 mM
KCl, 2.0 mM MgSO4, 1.2 mM Na2HPO4, 2.5 mM glucose,
0.5 mM carnitine, and 5 mM HEPES). FCCP (3 μM), ETO
(200 μM), and antimycin A (4 μM) were added subsequently at the indicated time. For measurements using
OA–BSA as substrate, OA–BSA (100 μM) was added to
the FAO assay medium replacing palmitate–BSA. All
OCR measurements were normalized to total protein
contents in each well. The basal, maximum, and reserved
FAO were calculated based on OCR measurements upon
the addition of mitochondrial inhibitors.
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were cultured in 3D Matrigel for 3 days and collected for
RT-PCR14.
Western blot analysis

Colon cancer cells or tumor organoids were collected
and detergent-solubilized cell lysates were obtained as
described previously8,14. The NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo) was used to separate
cytoplasmic and nuclear fractions. Equal amounts of total
cell lysates were resolved by SDS–PAGE and subjected to
Western blot analysis. The following antibodies, including
CPT1A, acetylated-lysine (pan-Lys, #9441) acetyl-histone
H3 (Lys9) (#9649), acetyl-histone H3 (Lys27) (#8173),
histone H3 (#14269), active-β-catenin (#8814), total
β-catenin (#8480), were purchased from Cell Signaling;
the acetyl-α-tubulin (T7451) and β-actin (A1978) antibodies were from Sigma-Aldrich; and the total α-tubulin
(sc-5286) and Lamin A/C (sc-20681) antibodies were
from Santa Cruz.

Fatty acid degradation assay

Cells were seeded in 96-well plates at a density of 1 ×
104 cells per well and incubated with OA (200 μM)
overnight. The cells were then switched to low glucose
medium supplemented with 10% FBS and ﬁxed in
paraformaldehyde at indicated time points. To quantify
the amount of lipids, the ﬁxed cells were stained
with BODIPY 493/503 (1 µg/ml) and the amount of
BODIPY ﬂuorescence was measured in cell lysates using
a SpectraMax M5 Microplate Reader. For visualizing
cellular lipid contents, cells were seeded onto coverslips
in six-well plates, loaded with OA and allowed to unload
for 24–48 h. The cells were then ﬁxed and stained with
BODIPY 493/503 and DAPI. The immunoﬂuorescence
images were obtained using a Nikon A1+ confocal
microscope.
Tumor organoid formation assay

Tumor organoids generated from Apc/Kras double
mutant mice were cultured as described previously8. To
silence Cpt1a expression, tumor organoids were dissociated into small cell clusters using TrypLE (Thermo)
and incubated with sh-Cpt1a lentivirus in suspension for
6 h in a 37 °C incubator. Cells were subsequently
embedded in 50% Matrigel in 3D growth medium
(Advanced DMEM/F12 supplemented with 1 × Glutamax,
1 × N-2, 1 × B-27, 1 mM N-acetyl-L-cysteine, and 1%
penicillin/streptomycin), and puromycin was added
2 days later to select for stable knockdown cells. To
determine the tumor initiation capacity, organoids were
dissociated to single cell suspensions using Accumax
(Sigma-Aldrich). Total of 1000 cells per group were
embedded in Matrigel as described above. The number of
tumor organoids formed after 6 days were counted and
analyzed. For gene expression analysis, tumor organoids
Ofﬁcial journal of the Cell Death Differentiation Association

Quantitative RT-PCR

Total mRNAs were isolated from cells using the RNeasy
Mini Kit (Qiagen). Equal amounts of RNA were subjected
to the reverse transcription PCR with the High Capacity
cDNA Reverse Transcription kit (Thermo). The cDNAs
obtained were subjected to RT-PCR reactions using the
SYBR Green Master Mix (Thermo) and primers listed in
Supplementary Table S1. To determine the expression of
human and mouse CPT1A, gene-speciﬁc probes were
purchased from Thermo and used in RT-PCR reactions
using Taqman Gene Expression Master Mix (Thermo).
All values were normalized to the level of β-actin.
Xenograft tumorigenesis

All animal procedures were done using protocols
approved by the University of Kentucky Animal Care and
Use Committee. Six to eight week-old NOD.Cg-Prkdcscid
IL2rgtm1Wjl/SzJ (NSG, The Jackson Laboratory) mice were
used. Both male and female mice of equal numbers were
included in each group. Mice were housed in barrier
rooms with 12-h light/dark cycle. For tumor growth assay,
control and CPT1A knockdown SW480 cells in 5%
Matrigel suspension (5 × 105 cells in 100 µl) were mixed
with 50 µl of freshly isolated human adipocytes (contain
~100,000 adipocytes) or PBS and inoculated subcutaneously. The tumor size was measured every week
with a caliper, and the tumor volume was deﬁned as
(longest diameter) × (shortest diameter)2/2. At the end of
experiments, tumors were harvested and subjected to
mRNA and protein analysis. For tumor initiation assay,
100 or 1000 SW480 cells were mixed with Matrigel and
adipocytes as described above and injected subcutaneously. The number of tumors formed was determined 3 months post injection.

Xiong et al. Cell Death and Disease (2020)11:736

Statistical analysis

In experiments to assess rate of FAO, relative cell survival,
mRNA expression, levels of Ac-CoA and colony formation
were summarized using bar graphs and pairwise comparisons between different conditions were carried out using
two-sample t-tests. For measuring the time course of fatty
acid degradation, one-way or two-way analysis of variance
models with two-way interaction terms for experimental
factors such as treatment group, cell types and time were
utilized. A linear mixed model was employed to compare
slope of tumor volume growth curves over time between
groups. The relative mRNA expression results represent
average of three separate RT-PCR experiments with four
replicates for each gene in each experiment. All other
experiments were repeated three times and results shown
represent the average of three experiments. Measurements
of xenograft tumor growth were summarized at each time
point of follow-up and analysis was performed using longitudinal models to account for repeatedly measured tumor
volume over time within each mouse. The stem cell frequencies were calculated by extreme limiting dilution analysis (ELDA)19 using analytic tools available at http://bioinf.
wehi.edu.au/ software/elda/.

Results
CTP1A expression is upregulated by fatty acids in colon
cancer

We have shown previously that fatty acids released by
adipocytes can be taken up by cancer cells to support cell
survival by upregulating FAO8. Here we further investigated the mechanisms by which fatty acids induce this
metabolic switch. To this end, we determined the expression of CPT1A in tumor specimens obtained from stage IV
colon cancer patients. Interestingly, the expression of
CPT1A was signiﬁcantly increased in tumor cells that have
invaded into the omental adipose tissue (adipocyte adjacent) compared to tumor cells without direct contact with
adipocytes (primary tumors) (Fig. 1a–d and Supplementary
Fig. S1). To examine the effect of fatty acids on CPT1A
expression directly, we co-cultured PT130, a patientderived colon cancer cell line, and SW480 cells with adipocytes. The CPT1A expression was markedly increased in
the presence of adipocytes as measured by quantitative RTPCR in colon cancer cells (Fig. 1e) and Western blotting
analysis (Fig. 1f). Additionally, PT130 and SW480 cells
were treated with OA, PA, or LA, three major fatty acid
species found in human adipose tissues20, and the
expression of CPT1A was consistently increased at both
protein and mRNA levels (Fig. 1f, g). In subsequent
experiments, OA or PA was used to examine CPT1Adependent effects in colon cancer cells. Together, these
results suggest that upregulation of CPT1A may provide a
necessary mechanism for cancer cells to adapt a fatty acidenriched microenvironment.
Ofﬁcial journal of the Cell Death Differentiation Association
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Silencing CPT1A alters cellular metabolism in colon cancer
cells

Given that CPT1A is the ﬁrst rate-limiting enzyme in
FAO, we next investigated the effect of silencing CPT1A
on cellular metabolism. Stable CPT1A knockdown PT130
and SW480 cells were generated using two different lentiviral shRNAs (Fig. 2a). To determine the rate of FAO,
the oxygen consumption rates (OCRs) were measured by
using palmitate as the metabolic substrate in control and
CPT1A knockdown cells with Seahorse XF96 Extracellular Flux Analyzer (Fig. 2b–e). We found that the
OCRs associated with basal, maximal. and reserved FAO
were signiﬁcantly decreased in CPT1A knockdown PT130
and SW480 cells (Fig. 2c, e), conﬁrming the role of
CPT1A in controlling mitochondrial FAO. Similar results
were obtained using OA as the metabolic substrate in
Seahorse measurements to conﬁrm that knockdown of
CPT1A decreases FAO in colon cancer cells (Supplementary Fig. S2). In addition, since FAO and glycolysis are
two functionally coupled metabolic processes that can be
utilized by cancer cells, we determined if knockdown of
CPT1A alters mitochondria-dependent glucose metabolism using Seahorse analysis (Supplementary Fig. S3).
Interestingly, when using glucose as the metabolic substrate, results from Seahorse Mito Stress Tests showed
that the OCRs associated with both basal and maximal
mitochondrial respiration as well as ATP production were
signiﬁcantly increased in CTP1A knockdown cells (Supplementary Fig. S3A–D). Moreover, measurements from
Seahorse Glycolysis Tests indicated that the extracellular
acidiﬁcation rate (ECAR) was increased in CTP1A
knockdown cells (Supplementary Fig. S3E–H). These
results are consistent with previous reports that ETO
treatment can increase glucose uptake in normal and
malignant cells21,22. Taken together, our results suggest
that downregulation of CPT1A impairs FAO in colon
cancer cells. However, this decreased FAO can be compensated by increased glucose metabolism. Indeed, we did
not observe signiﬁcant changes in the rate of cell proliferation in CTP1A knockdown cells when cultured in
regular growth medium containing sufﬁcient supplies of
glucose (Supplementary Fig. S4).
Knockdown CPT1A impairs fatty acid utilization and cell
survival under nutrient deprivation conditions

To address the question if upregulation of CPT1A is
necessary for cancer cells to utilize the exogenous fatty
acids, control and CPT1A knockdown PT130 and SW480
cells were treated with OA for 24 h (the loading phase)
and subsequently cultured in low glucose media for additional 24–48 h (the unloading phase) to allow the preferential utilization of fatty acids. Upon loading cells with
OA, similar levels of lipid droplets accumulation were
detected in control and CPT1A knockdown cells using
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Fig. 1 The expression of CTP1A is upregulated by fatty acids in colon cancer. a–c The expression of CPT1A protein was detected in a stage IV
colon cancer patient tissues using IHC staining. The black-boxed and blue-boxed regions shown in a were enlarged and presented in b and c,
respectively. Scale bar, 100 μm. d Quantitative analysis of CPT1A expression in specimens from 11 stage IV colon cancer patients. The percentage of
invasive tumor cells in areas adjacent to adipocytes with positive CPT1A expression was higher than that of non-invasive primary tumors. Data
represents mean ± SD (n = 11, *p < 0.01). e PT130 and SW480 cells were co-cultured with adipocytes isolated from colon cancer patients for 2 days.
The levels of CPT1A mRNA expression were analyzed using RT-PCR. Data represents mean ± SD (n = 3, ¶p < 0.0001 and *p < 0.01). f Protein lysates
prepared from cells co-cultured with adipocytes as described in e or treated with BSA, OA, PA, and LA (100 μM of each fatty acid species) for 24 h
were analyzed for CPT1A protein expression using Western blotting. The relative levels of CPT1A were quantiﬁed by normalizing to β-actin and
compared to control or BSA-treated cells. g PT130 and SW480 cells treated with BSA, OA, PA, or LA as described in f were analyzed for the expression
of CPT1A mRNA using RT-PCR. Data represents mean ± SD (n = 3, §p < 0.001 and ¶p < 0.0001).

Ofﬁcial journal of the Cell Death Differentiation Association
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Fig. 2 Knockdown of CPT1A inhibits fatty acid oxidation in colon cancer cells. a The expression of CPT1A protein was analyzed in stable control
and CPT1A knockdown PT130 and SW480 cells using Western blotting. Two different shRNA targeting sequences (C6 and C7) were used to silence
CPT1A in each cell line. β-actin was used as loading controls. b Representative OCR measurements obtained from the FAO tests performed in control
(sh-Control) and CPT1A knockdown (sh-CPT1A-C6 and sh-CPT1A-C7) PT130 cells using the Seahorse XF96 Extracellular Flux analyzer. FCCP, ETO, and
antimycin A (Anti-A) were added at the indicated points. c Experiments as shown in b were quantiﬁed and the relative levels of OCR associated with
basal FAO, FAO capacity, and FAO reserve were calculated based on the measurements obtained from the addition of different compounds. Data
represent the mean ± SD (n = 3, ¶p < 0.0001 and *p < 0.01). d Representative OCR measurements obtained from the FAO tests in sh-control, shCPT1A-C6, and sh-CPT1A-C7 SW480 cells using the Seahorse XF96 Extracellular Flux analyzer. e The relative levels of OCR associated with basal FAO,
FAO capacity, and FAO reserve were quantiﬁed. Data represent the mean ± SD (n = 3, #p < 0.05, *p < 0.01, and §p < 0.001).

BODIPY-493/505 staining (Fig. 3a). However, while
BODIPY-staining of lipid droplets diminished in the
unloading phase in control cells, signiﬁcant levels of
BODIPY-staining remained in CPT1A knockdown cells
(Fig. 3a). Moreover, the relative lipid content was quantiﬁed by measuring BODIPY ﬂuorescence intensity at different time points following OA treatment. The time
course of fatty acids degradation was signiﬁcantly delayed
in CPT1A knockdown PT130 and SW480 cells as indicated
by increased BODIPY retention compared to control cells
(Fig. 3b).
Furthermore, we determined if silencing CPT1A disrupts the protective effect provided by fatty acid uptake.
Control and CPT1A knockdown PT130 and SW480
cells were co-cultured with adipocytes or treated with
OA for 24 h and subsequently cultured in EBSS buffer
Ofﬁcial journal of the Cell Death Differentiation Association

for additional 48 h (Fig. 3c–f). Our results showed that
both co-culturing with adipocytes and OA treatment
signiﬁcantly increased the survival of control PT130 and
SW480 cells under nutrient deprivation conditions.
However, the pro-survival effect provided by adipocytes
and fatty acids was largely abolished in CPT1A knockdown cells (Fig. 3c–f). Taken together, our results
demonstrate that uptake of fatty acids renders colon
cancer cells resistant to nutrient deprivation and
this acquired survival advantage relies on CPT1Amediated FAO.
Downregulation of Cpt1a reduce cancer stem cell
properties in 3D tumor organoids

We have previously shown that the presence of adipocytes increases the expression of genes associated with
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Fig. 3 (See legend on next page.)
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(see ﬁgure on previous page)
Fig. 3 Knockdown of CPT1A impairs fatty acid utilization and cell survival under nutrient deprivation conditions. a Stable control (shControl) and CPT1A knockdown (sh-CPT1A-C6 and sh-CPT1A-C7) PT130 and SW480 cells were incubated with OA for 24 h (loading) and subsequently
allowed to grow in regular growth medium for additional 24 or 48 h for PT130 and SW480 cells, respectively (unloading). Representative confocal
images of cells stained with BODIPY 493/503 (green) and DAPI (blue). Scale bar, 100 μm. b Control and CPT1A knockdown PT130 and SW480 cells
were incubated with OA for 24 h (day 1) and subsequently were stained with BODIPY 493/503 at indicated time points (days 2–4). The ﬂuorescence
intensity was measured using a ﬂuorescence spectrophotometer as readout for relative lipid contents in cells. Data represent the mean ± SD (n = 3,
#
p < 0.05, *p < 0.01, and ¶p < 0.0001). c and d Control and CPT1A knockdown PT130 cells were co-cultured with adipocytes c or pretreated with OA
d for 24 h and subsequently cultured in EBSS for additional 48 h. The relative cell survival was measured using crystal violet staining. Data represent
the mean ± SD (n = 3, #p < 0.05). e and f Control and CPT1A knockdown SW480 cells were co-cultured with adipocytes e or pretreated with OA f for
24 h and subsequently cultured in EBSS for additional 48 h. The relative cell survival was determined. Data represent the mean ± SD (n = 3, #p < 0.05
and §p < 0.001).

cancer stem cells in intestinal tumor organoids derived
from Apc/Kras double mutant mice8. Here we investigated
if upregulation of CPT1A is required to mediate the effect
of adipocytes on promoting cancer stem cell functions.
First, the Apc/Kras tumor organoids were embedded with
adipocytes in 3D Matrigel or treated with different fatty
acids and the expression of Cpt1A was monitored using
Western blot and RT-PCR analysis. Consistent with
results shown in Fig. 1, the presence of adipocytes or fatty
acids increased Cpt1a expression at both protein and
mRNA levels (Fig. 4a, b). Next, we silenced the expression
of Cpt1a using lentiviral shRNA in Apc/Kras organoids.
Interestingly, while control tumor cells formed spherical
organoids in 3D, the Cpt1a knockdown organoids showed
branched phenotype suggesting potential differentiation
(Fig. 4c). Moreover, single cell suspensions of control and
Cpt1a knockdown cells were seeded in 3D Matrigel and
the numbers of colonies formed were determined after
6 days. We found that the ability of Cpt1a knockdown cells
to form colonies in 3D was signiﬁcantly decreased whereas
the percentage of organoids with the branched phenotype
was increased (Fig. 4d). Similar reduction in colony formation and increase in differentiation were observed in
Apc/Kras organoids treated with ETO, an inhibitor of
CPT1A (Supplementary Fig. S5A and B). In addition, since
the 3D growth media are enriched in fatty acids, silencing
Cpt1a also reduced the rate of cell proliferation in tumor
organoids (Supplementary Fig. S5C). However, the
reduced colony formation was not due to decreased cell
survival as knockdown of Cpt1a had no effect on cell
viability (Supplementary Fig. S5D).
Consistent with the notion that Wnt signaling activation
is required to promote cancer stem cell properties23,24, we
found that treating tumor organoids with three different
fatty acids signiﬁcantly increased expression of Wnt target
genes and decreased genes associated with intestinal epithelial cell differentiation (Fig. 4e). Moreover, knockdown
of Cpt1a largely reduced the expression of genes associated
with CSCs downstream of Wnt/β-catenin and increased
the expression of differentiation markers (Fig. 4f). Furthermore, while fatty acid treatment signiﬁcantly increased
Ofﬁcial journal of the Cell Death Differentiation Association

the expression of Wnt target genes, silencing Cpt1a
expression abolished the effect of fatty acids (Fig. 4g).
Collectively, our results suggest that fatty acid treatment
enhances Wnt signaling in tumor organoids using a
CPT1A-dependent mechanism.
Fatty acids increase CPT1A expression and Wnt signaling
through PPARδ in colon cancer

To determine the molecular mechanism by which fatty
acids and adipocytes promote CPT1A expression, we
investigated the functional contribution of peroxisome
proliferator-activated receptor δ (PPARδ). PPARδ is a
lipid sensing nuclear receptor that can be activated by
long-chain fatty acids to regulate cellular metabolism25.
Previous studies have shown that PPARδ play a critical
role in controlling FAO in muscle or adipocytes tissues
and high-fat diet enhance tumor initiation potential of
intestinal organoids in by activating PPARδ26,27. To conﬁrm the involvement of PPARδ in regulating CPT1A, we
showed that treating PT130 cells or Apc/Kras tumor
organoids with PPARδ agonist GW501516 directly stimulated the expression of CPT1A and PPARGC1A (a
known PPARδ target gene) (Fig. 5a, b). In addition, fatty
acid-induced upregulation of CPT1A was effectively
blocked by pretreating cells with PPARδ antagonist
GSK3787 (Fig. 5c, d). Importantly, inhibition of fatty acidinduced PPARδ activation decreased the expression of
Wnt-targeting genes (Fig. 5e) in tumor organoids. Collectively, our data indicate that fatty acids stimulate
CPT1A expression to enhance FAO and Wnt signaling
mainly through PPARδ activation in colon cancer cells.
Downregulation of CPT1A decreases β-catenin acetylation
and activation

We next determined the mechanism underlying fatty
acid-induced activation of Wnt signaling. The FAO has
been identiﬁed as a major carbon source for the production of cellular Ac-CoA, a central metabolite that
regulates protein acetylation16,28. Here we examined
whether CPT1A downregulation alters cellular Ac-CoA
levels. As shown in Fig. 6a, knockdown of CPT1A
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Fig. 4 CPT1A-dependent fatty acid oxidation promotes Wnt signaling and cancer stem cell properties. a Tumor organoids derived from Apc/
Kras double mutant mice were embedded with adipocytes in 3D Matrigel or treated with BSA, OA, PA, and LA (100 μM each) for 2 days. The levels of
Cpt1a expression were analyzed using Western blotting. The relative levels of CPT1A were quantiﬁed by normalizing to β-actin and compared to
control or BSA-treated cells. b Tumor organoids treated as described in a were analyzed for the expression of Cpt1a mRNA using RT-PCR. Data
represents mean ± SD (n = 3, *p < 0.01, §p < 0.001, and ¶p < 0.0001). c The expression of Cpt1a was silenced in Apc/Kras mutant tumor organoids
using lentiviral shRNA. Single cell suspensions of control and Cpt1a knockdown cells were seeded in 3D Matrigel. Representative images of control
and Cpt1a knockdown tumor organoids are shown after 6 days in culture. Scale bar, 100 μm. d The number of tumor organoids formed and the
percentage of organoids showed branching phenotype were quantiﬁed (total 1000 cells were seeded per group). Data represent the mean ± SD
(n = 3, #p < 0.05). e Tumor organoids treated with BSA, OA, PA, and LA (100 μM each) were analyzed for the expression of Wnt β-catenin target genes
(including Lgr5, Axin2, and Tcf7) and genes associated with intestinal epithelial cell differentiation (including Krt20 and Muc2) using RT-PCR. Data
represents mean ± SD (n = 3, #p < 0.05, *p < 0.01, §p < 0.001, and ¶p < 0.0001). f Control and Cpt1a knockdown organoids were subseeded and grown
in 3D Matrigel for 3 days. The expression of Cpt1a, Wnt/β-catenin target genes (including Lgr5, Axin2, and Myc), and genes associated with intestinal
epithelial cell differentiation (including Krt20 and Muc2) was determined using RT-PCR. Data represent the mean ± SD (n = 3, *p < 0.01 and
§
p < 0.001). g Control and Cpt1a knockdown organoids were treated with OA for 2 days. The mRNA expression of Cpt1a as well as target genes of
Wnt/β-catenin (including Lgr5 and Myc) was determined using RT-PCR. Data represent the mean ± SD (n = 3, *p < 0.01).

signiﬁcantly reduced total Ac-CoA levels in both PT130
and SW480 cells. Given that fatty acid-derived Ac-CoA
can be used as substrate for protein acetylation and
acetylation of β-catenin enhances Wnt signaling by
promoting β-catenin nuclear localization29–31, we
investigated whether the reduced acetyl-CoA production affects β-catenin activity. To this end, endogenous
β-catenin proteins were immunoprecipitated from
PT130 cells treated with BSA or OA and the level of
β-catenin acetylation was determined using an
acetylated-lysine antibody. Indeed, treatment with OA
increased β-catenin acetylation (Fig. 6b). Moreover,
knockdown of CPT1A markedly reduced levels of
β-catenin acetylation in PT130 and SW480 cells suggesting CPT1A-dependent FAO controls β-catenin
acetylation (Fig. 6c). Consistent with the notion that
acetylation of β-catenin increases its activity, results
from Western blot analysis showed that the levels of
active β-catenin (non-phosphorylated form) were
decreased in CPT1A knockdown PT130 and SW480
cells (Fig. 6d). As controls, we analyzed the acetylation
status of α-tubulin, a cytoplasmic substrate, and histone
H3, a nuclear substrate, at lysine 9 (H3K9) and lysine 27
(H3K27) residues. Consistently, the levels of Ac-αtubulin as well as H3K9Ac and H3K27Ac were reduced
in CPT1A knockdown cells conﬁrming that FAO is
important for regulating a broad range of protein acetylation events (Fig. 6d). Similar decrease in the levels of
active β-catenin and acetylated α-tubulin, H3K9 and
H3K27 was observed in Cpt1a knockdown tumor
organoids (Supplementary Fig. S6A). To further determine the functional effect of decreased β-catenin acetylation, control and CPT1A knockdown PT130 and
SW480 cells were fractionated into cytoplasmic and
nuclear fractions. The amount of β-catenin in the
nuclear factions was decreased in CPT1A knockdown
PT130 and SW480 cells conﬁrming that acetylation of
β-catenin promotes its nuclear localization (Fig. 6e, f).
Ofﬁcial journal of the Cell Death Differentiation Association

Furthermore, control and CPT1A knockdown PT130
cells treated with PA were subjected to Western blot
analysis to determine the functional contribution of
CPT1A-dependent FAO in regulating protein acetylation.
Results showed that PA treatment increased levels of
active β-catenin as well as acetylated α-tubulin, H3K9, and
H3K27 in control cells whereas silencing CPT1A blocked
the effect of fatty acids on β-catenin activation and protein
acetylation (Fig. 6g). Similar results were obtained in
control and CPT1A knockdown cells treated with OA
(Supplementary Fig. S6B). As a control, we treated cells
with octanoate, a medium-chain fatty acid that can enter
mitochondria and undergo FAO independent of
CPT1A16. Interestingly, octanoate treatment markedly
increased the levels of acetylated α-tubulin, H3K9, and
H3K27 as well as active β-catenin in both control and
CPT1A knockdown cells (Fig. 6h). Consistent with a dosedependent effect of octanoate on modulating protein
acetylation16, we showed that treating cells with a lower
concentration of octanoate partially rescued the acetylation defect observed in CPT1A knockdown cells (Supplementary Fig. S6C). Taken together, our results suggest
the acetyl-CoA derived from long-chain FAO can be used
as the substrate for protein acetylation in a CPT1Adependent manner. Because free fatty acids derived from
adipocytes are in the form of long-chain fatty acids,
upregulation of CPT1A allows the cancer cells to produce
increasing levels of Ac-CoA via mitochondrial FAO to
promote β-catenin activation and Wnt signaling.
Knockdown of CPT1A inhibits xenograft tumor growth and
tumor initiation in vivo

To examine the effect of silencing CPT1A on tumor
growth in vivo, we subcutaneously injected control and
CPT1A knockdown SW480 cells mixed with Matrigel
alone or in combination with human adipocytes into NSG
mice and monitor the tumorigenesis process. Consistently
with the tumor promoting effect of adipocytes, the rate of
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Fig. 5 Fatty acids activate PPARδ to promote CPT1A expression and Wnt signaling in colon cancer cells. a PT130 cells were treated with
PPARδ agonist GW501516 (1 μM) for 24 h. The expression of CPT1A and PPARGC1A was determined using RT-PCR. Data represent the mean ± SD
(n = 3, ¶p < 0.0001). b Apc/Kras tumor organoids were treated with PPARδ agonist GW501516 (1 μM) for 48 h. The expression of Cpt1a and Ppargc1a
was determined using RT-PCR. Data represent the mean ± SD (n = 3, *p < 0.01 and §p < 0.001). c PT130 cells were treated with OA alone or in
combination with PPARδ antagonist GSK3787 (1 μM) for 24 h. The expression of CPT1A was determined using RT-PCR. Data represent the mean ± SD
(n = 3, #p < 0.05,§p < 0.001, and ¶p < 0.0001). d PT130 cells were treated with PA alone or in combination with PPARδ antagonist GSK3787 (1 μM) for
24 h. The expression of CPT1A and PPARGC1A was determined using RT-PCR. Data represent the mean ± SD (n = 3, §p < 0.001 and ¶p < 0.0001).
e Apc/Kras tumor organoids were treated with OA alone or in combination with PPARδ antagonist GSK3787 (1 μM) for 48 h. The expression of Cpt1a,
Ppargc1a, and Wnt/β-catenin target genes (including Lgr5, Myc, and Axin 2) was determined using RT-PCR. Data represent the mean ± SD (n = 3,
#
p < 0.05, *p < 0.01, §p < 0.001, and ¶p < 0.0001).

tumor growth was largely increased when the control
SW480 cells were co-injected with adipocytes (Fig. 7a).
Although knockdown of CPT1A did not signiﬁcantly
decrease the tumor growth rate basally compared to the
control group, CPT1A-loss blocked the tumor promoting
effect of adipocytes in vivo (Fig. 7a). Analysis of tumor
tissues collected from four groups of mice revealed that
knockdown of CPT1A decreased the amount of active
β-catenin, although we did not observe the adipocyteinduced activation of β-catenin in tumors derived from
control cells (Fig. 7b, c). It is likely that the effect of adipocytes on promoting protein acetylation gradually
diminished as adipocytes did not expect to survive the
Ofﬁcial journal of the Cell Death Differentiation Association

entire tumorigenesis process. Nevertheless, results from
RT-PCR analysis showed that the expression of CPT1A
and Wnt target genes (including LGR5 and MYC) was
elevated in control SW480 cells that co-injected with
adipocytes and knockdown of CPT1A largely abolished
this effect (Fig. 7d).
Furthermore, we performed tumor initiation experiments by injecting control and CPT1A knockdown
SW480 cells mixed with Matrigel alone or in combination
with adipocytes into NSG mice at 100 and 1000 cells per
site. The number of tumors formed was determined after
3 months. Based on an ELDA, co-injection of adipocytes
signiﬁcantly increased the stem cell frequency in control
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Fig. 6 Downregulation of CPT1A decreases cellular levels of acetyl-CoA and protein acetylation. a Control and CPT1A knockdown PT130 and
SW480 cells were cultured in low glucose media supplemented with 10% FBS. The levels of acetyl-CoA in control and CPT1A knockdown PT130 and
SW480 cells were determined using the Acetyl-CoA Assay kit. Data represent mean ± SD (n = 3, #p < 0.05 and *p < 0.01). b PT130 cells were treated
with BSA or OA (100 μM) for 24 h. Cell lysates were immunoprecipitated using the anti-β-catenin antibody and analyzed for the levels of β-catenin
acetylation using the acetylated-lysine antibody (Ac-Lys). The blot was stripped and reprobed for total β-catenin in the immunoprecipitates. c Cell
lysates from control and CPT1A knockdown PT130 or SW480 cells were immunoprecipitated and analyzed for the levels of β-catenin acetylation
using the acetylated-lysine antibody (Ac-Lys). The blot was stripped and reprobed for total β-catenin in the immunoprecipitates. d Cell lysates from
control and CPT1A knockdown PT130 or SW480 cells were analyzed for the levels of active-β-catenin as well as acetyl-α-tubulin (Ac-α-tubulin), acetylhistone at K9 and K27 residues (H3K9Ac and H3K27Ac) using Western blotting. Total β-catenin, α-tubulin, histone H3, and β-actin were used as
loading controls. e and f Control and CPT1A knockdown PT130 e and SW480 f cells were fractionated into cytoplasmic and nuclear fractions. The
amount of β-catenin in each fraction was determined using the anti-β-catenin antibody. α-Tubulin and lamin A/C were used as controls for the
cytoplasmic and nuclear fractions, respectively. g Control and CPT1A knockdown PT130 cells were treated with BSA or PA (100 μM) for 24 h and cell
lysates were analyzed for the levels of active-β-catenin as well as Ac-α-tubulin, H3K9Ac, and H3K27Ac using Western blotting. h Control and CPT1A
knockdown PT130 cells were cultured under control condition or treated with octanoate (3 mM) for 24 h and cell lysates were analyzed for the levels
of active-β-catenin as well as Ac-α-tubulin, H3K9Ac, and H3K27Ac using Western blotting.

cells (from 1 in 458 basally to 1 in 102 in the presence of
adipocytes) but not in CPT1A knockdown cells (Fig. 7e).
Taken together, our results suggest that CPT1A is
required for adipocytes to enhance the tumor initiation
potential in vivo.
In summary, results from this study support a model
in which uptake of fatty acids activates PPARδ-dependent transcription of CPT1A and CPT1A-dependent
FAO. Subsequently, increased production of Ac-CoA
and the acetylation of β-catenin promote Wnt signaling
and cancer stem cell function. Thus, pharmacological
inhibition of CPT1A with ETO or knockdown of
CPT1A expression may block fatty acids-induced
tumor promoting effects in colon cancer (Supplementary Fig. S6D).

Discussion
Several large prospective epidemiological studies have
provided strong evidence supporting the role of obesity in
promoting colon cancer initiation and progression5,32,33.
However, the molecular mechanism underlying how adipose tissue and adipocytes support tumor growth and
progression remains largely unknown. We have shown
previously that abundant adipocytes are found in direct
contact with colon cancer cells and uptake of fatty acids
released by adipocytes promotes cancer cell survive by
upregulating mitochondrial FAO8. Results from this study
demonstrate that the presence of adipocytes or fatty acids
stimulates the expression of CPT1A by activating PPARδdependent transcription. Silencing CPT1A expression in
colon cancer cells blocks the cell survival advantage
provided by adipocytes as a result of decreased fatty acid
degradation via FAO. In addition, CPT1A downregulation
induces differentiation of tumor organoids grown in 3D
and attenuates the effect of fatty acids on promoting the
expression of cancer stem cell-associated genes. Importantly, CPT1A expression is required for adipocytes to
promote tumor growth and initiation in vivo.
Ofﬁcial journal of the Cell Death Differentiation Association

The cancer stem cells, also known as tumor-initiating
cells, have been implicated in tumor initiation, recurrence,
and metastasis34–36. Emerging evidence suggests that
Wnt/β-catenin signaling is required for the maintenance
of normal and cancer stem cells37. Despite having activating mutations in the Wnt pathway, colon cancer cells
with the highest levels of β-catenin signaling display
cancer stem cell properties23. Consequently, the expression levels of β-catenin target genes have been used as a
readout for the stemness of cancer stem cells38. Recent
studies have begun to establish the role of FAO in regulating normal and cancer stem cell function. For example, it has been shown that CPT1A-dependent FAO is
required for the maintenance of tumor initiation cells in
hepatocellular carcinoma as well as normal hematopoietic
and neural stem cells39–41. Moreover, deletion of Cpt1a in
mouse intestine epithelium decreases the number and
function of normal intestinal stem cells42. Our study
identiﬁes CPT1A upregulation as a key metabolic alteration that cancer cells adapt to promote β-catenin acetylation and activation in an adipocyte-enriched TME.
Since uptake of fatty acids induces the acetylation of
proteins other than β-catenin, additional studies are
needed to determine the functional contribution of these
acetylation events. It is of particular interest to further
investigate the epigenetic alterations associated with histone acetylation changes induced by fatty acids.
In addition, it has been shown recently that CPT1
complex may support cell proliferation independent of its
ability to control FAO43. Although we show that inhibition of FAO is coupled with decreased cell survival and
β-catenin activation in CPT1A knockdown cells, it is
possible that CPT1A mediates the tumor promoting
effects of adipocytes using a FAO-independent mechanism. Moreover, a recent study reported that circulating
fatty acid-binding protein released by adipose tissue
(A-FABP or FABP4) promotes breast cancer stemness by
activating the IL-6/STAT3/ALDH1 pathway44. The
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Fig. 7 CPT1A is required to mediate the tumor promoting effect of adipocytes in vivo. a Control and CPT1A knockdown SW480 cells were
mixed with Matrigel alone or in combination with adipocytes and injected subcutaneously into NSG mice. The size of the tumors was measured
every 5 days for 51 days. Data represent the mean ± SEM (n = 6, for sh-Control and sh-CPT1A group; and n = 7 for sh-Control + adipocytes and shCPT1A + adipocytes group, #p < 0.05 and *p < 0.01; NS = not signiﬁcant). b Tumor tissues from three mice of each group were analyzed for the levels
of CPT1A, active-β-catenin, and β-catenin using Western blotting. c Quantitative analysis of relative active-β-catenin levels in xenograft tumors from
four different groups of mice. The levels of active-β-catenin were normalized to total β-catenin in each sample. Data represent the mean ± SD (n = 3,
*p < 0.01). d Tumor tissues from three mice of each group were analyzed for the expression of CPT1A, LGR5, and MYC using RT-PCR. Data represent
the mean ± SD (n = 3, #p < 0.05, *p < 0.01, §p < 0.001, and ¶p < 0.0001). e Tumor initiation experiments were performed using control and CPT1A
knockdown SW480 cells. Cells were mixed with Matrigel alone or in combination with adipocytes and injected into NSG mice at 100 or 1000 cells per
site and total eight injections were used for each cell group. The number of tumors formed was determined 3 months post inoculation. The stem cell
frequency was calculated using extreme limiting dilution analysis (ELDA) (&p = 0.01, comparing sh-control group with sh-control + adipocytes group;
and **p = 0.0003, comparing sh-control + adipocytes group with sh-CPT1A + adipocytes group).

importance of FABP4 in facilitating the transport of fatty
acids from adipocytes to cancer cells has also been shown
in ovarian and colon cancers7,8. Results from our study
here provide strong evidence supporting a role of CPT1A
in controlling the production of signaling metabolites to
mediate the communication between adipocytes and
colon cancer cells. Future studies are needed to further
determine the role of FABP4 in regulating cancer stemness in colon cancer.
In summary, results from our study identify CPT1A as a
key regulator that connects adipocyte-mediated regulation
of cellular metabolism to Wnt signaling in colon cancer
cells. Given the preferential upregulation of CPT1A by
adipocytes, our ﬁndings indicate that inhibition of CPT1A
may provide an effective approach to block the tumor
promoting effects of adipocytes in colon cancer.
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